Health insurance is the global trend in the next decade. As more attention given to this industry, the cost of international student insurance (aka 留学生保险) and OPT insurance (aka opt 保险) will increase accordingly. UC Berkeley published insurance waiver (aka 加利福尼亚大学伯克利分校替换保险) requirements to enable students from low-income families to continue their academia.

The new addition of insurance benefits such as high coinsurance in eyeglasses and contacts in the United States (aka 美国配眼镜) and the easy procedure of insurance waive (aka 替换保险) are attractive.

However, the long waiting period for a scheduled appointment in America and the high copayment dull students to rather travel back home than take physical examination in the United States (aka 美国体检).

On the Global Health Forum of Boao Forum for Asia opened in the eastern city of Qingdao, a congratulatory letter from President Xi Jinping expounded China’s efforts in deepening medical and healthcare system reform and its achievements in inheriting and developing the Traditional Chinese Medicine (TCM).

TCM focuses on harnessing the body’s ability to regulate itself, which aims at improving a person’s self-healing ability, rather than simply detecting and curing diseases.

A total of 139 new medicines developed by Chinese researchers have been certificated thanks to a major national science and technology project, officials said at a press conference. Among the list, 44 are Class I new drugs, which have never been marketed in China or overseas, said Liu Dengfeng, deputy director of the project’s implementation and management office.

China’s pharmaceutical industry has accelerated the process of industrialization. As of the end of 2018, over 280 generic medicines have been registered in Europe and the United States, while four vaccines and 23 chemical preparations have been pre-approved by the World Health Organization, according to Liu.

The project is led by the Ministry of Science and Technology and the National Health Commission. Launched in 2008, it aims to develop medicines for critical diseases.

Chen Kaixian, the deputy chief technical engineer of the project and an academician of the Chinese Academy of Sciences, revealed the information of 14 newly approved domestic drugs, mainly for patients with malignant tumors, AIDS and skin diseases.

Chen said the project will strengthen research efforts and explore new directions, to make more effective and affordable medicines for Chinese people.